Koo H, Mattay V, Hofling AA, Wang SJ, et al. Advancing Theranostics in Alzheimer Disease: FDA Approval of Amyloid-beta PET Drugs for Selection of Patients for Amyloid-beta-Directed Therapies and Other Labeling Updates. J Nucl Med 2026 Feb 19:jnumed.125.271312. doi: 10.2967/jnumed.125.271312.
PMID: 41714121